Silver Bullet Therapeutics launches OrthoFuzIon® bone screws

2021-12-14 10:46:51 By : Mr. Jack Yang

October 25, 2021 00:30 ET | Source: Silver Bullet Therapeutics, Inc. Silver Bullet Therapeutics, Inc.

San Jose, California, U.S.

San Jose, California, October 25, 2021 (Global News Agency) - Silver Bullet Therapeutics, Inc., a private medical device company, announced today that it will officially launch its antibacterial OrthoFuzIon bone screw system Doctor of Orthopedics and Traumatology at the DKOU German Conference Held in Berlin from October 26th to 29th.

The OrthoFuzIon product line of Silver Bullet Therapeutics will be exhibited at Nr's Argomedical booth. 61 is in Hall 4.2.

OrthoFuzIon Orthopedic Bone Screw System is a comprehensive antibacterial bone screw product line for orthopedic surgery. OrthoFuzIon bone screws are suitable for open reduction and internal fixation (ORIF) fracture surgery, and are electroplated in patients at risk of implant infection to inhibit microbial colonization and reduce implant infections or initial surgery caused by implants in repair surgery Related infections.

Paul Chirico, President and CEO of Silver Bullet Therapeutics, said: "Silver Bullet is pleased to launch our product line with our respected distribution partner Argomedical at the prestigious German Orthopaedic Association. Those who have undergone revision surgery due to implant-related infections Patients or patients who are at risk of implant infection due to initial surgery will benefit from this technology and a wide range of product offerings."

"Orthopedic trauma surgeons treat challenging injuries in patients who may have complicated medical comorbidities. I believe the Silver Bullet Therapeutics antibacterial OrthoFuzIon bone screw series can provide antibacterial silver ions around local implants, which will help us reduce the number of operations after surgical fixation. Complications of infection", the internationally renowned orthopedic trauma surgeon and orthopedic professor Amir Matityahu, MD, pointed out that the director of surgery at the University of California, San Francisco, the director of orthopedics and the director of orthopedic trauma at the San Jose Regional Medical Center. He is also a Fellow of the American Academy of Orthopaedic Surgery and International Correspondent of the German Orthopedics and Trauma Society (Deutsche Gesellschaft für Orthopädie und Unfallchirurgie e V.).

Phil Kropf, CEO of Argomedical, said: “Argomedical has a proud history of representing the most advanced products that directly benefit patients and surgeons.” “Silver Bullet Therapeutics’ antibacterial OrthoFuzIon bone screw system is not only simple, but also a destructive medical treatment. Equipment can almost immediately change the practice of trauma and orthopedics."

According to an article published by Hackett et al. in the Journal of the American Academy of Orthopaedic Surgery in 2015: “Musculoskeletal infections are the main reason for the increase in patient morbidity and health care expenditures. The incidence of musculoskeletal infections, including soft tissue infections, Periprosthetic joint infections and osteomyelitis are increasing. Cases involving drug-resistant bacterial strains and joint infections around prostheses in total hip and total knee arthroplasty are particularly expensive and are a growing issue for the U.S. medical system Economic burden.” Silver Bullet Therapeutics has developed a coating for bone screws because they can penetrate the cortical shell of the bone into the intramedullary space, which can not only reduce the incidence and cost associated with orthopedic infection complications, but also It can minimize the care of high-risk patients.

Silver Bullet Therapeutics has established an extensive intellectual property portfolio that enables the company to develop and validate coating processes for various metals, polymers, and electronic medical devices.

About Silver Bullet Therapeutics Silver Bullet Therapeutics, Inc., located in San Jose, California, has developed and patented an antimicrobial coating that addresses surgical sites and hospital-acquired infections by preventing microbial colonization of implanted medical devices. The company's first product, OrthoFuzIon bone screw system, uses Silver Bullet Therapeutics' proprietary platinum and silver technology, called AntiBacterIon, which rapidly ionizes silver and forms an antibacterial area around bone screws in any part of the body. Silver Bullet Therapeutics has developed and validated processes that can coat various equipment including metal and polymer equipment. OrthoFuzIon™ and AntiBacterIon™ are trademarks of Silver Bullet Therapeutics, Inc. and are awaiting FDA approval and have not yet been approved for sale in the United States.

About Argomedical Since 1989, Argomedical has developed, produced and sold high-quality products for orthopedics and traumatology. The conscientious management and well-organized and enthusiastic team create a perfect environment for stakeholders and customers. We have developed solutions in cooperation with recognized multidisciplinary experts and enabled a large number of operators to use our products. As a globally recognized Swiss manufacturer with a dedicated German subsidiary, we guarantee quality, repeatability and innovation. We provide rapid development, modern technology and manufacturing services. Permanent contact with experts and loyal customers makes scientific verification possible. Only through continuous innovation can we achieve sustained success. Argomedical is focused and clearly focused on selected surgical specialties.